TCG Crossover GP II, LLC - 27 Dec 2024 SCHEDULE 13G Report for RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share (RAPT)

Filing Manager
TCG Crossover GP II, LLC
Reporting Manager
TCG Crossover GP II, LLC
Security
RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
RAPT
Shares outstanding
132,063,163 shares
Disclosed Ownership
13,193,110 shares
Ownership
9.99%
Form type
SCHEDULE 13G
Filing time
03 Jan 2025, 16:08:01 UTC
Date of event
27 Dec 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TCG Crossover GP II, LLC 9.99% 13,193,110 0 13,193,110 /s/ Craig Skaling Authorized Signatory
TCG Crossover Fund II, L.P. 9.99% 13,193,110 13,193,110 0 /s/ Craig Skaling Authorized Signatory
Chen Yu 9.99% 13,193,110 0 13,193,110 /s/ Craig Skaling By POA as Attorney-in-Fact